Explain this page
Arphra AIPlain-English read on IQVIA Holdings Inc.’s valuationAI Issuer Brief
Arphra AILoading cached brief…
Fair value
Football field →Weighted blend
$399.22
+133.08% vs spot
Recommendation
Strong Buy
14 of 16 methods
Method spread
9bull3bear
±5% threshold
Analyst PT consensus: $225.63 (+31.73%)
Candlestick · 1Y
Open in chart workstation →IQV
167.77+5.80%H 247.05L 154.50MA50 173.26MA200 195.32Avg vol 1.7M
Price change · trailing returns
Live| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +2.07% | +2.18% | +2.01% | +3.12% | -24.22% | -24.01% | +8.01% | -19.90% | -28.90% | +170.50% | +306.74% |
Insider · 30d
History →Bought
$0
0 txns
Sold
$22.68M
10 txns
Net flow
−$22.68M
Aftermarket
LiveLast trade
$170.60
75 sh
Bid
$165.76
1 sh
Ask
$172.99
1 sh
Spread
$7.230
Recent quarters
All financials →| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q4 Dec 2025 | $4.36B | $514M | $2.99 |
| Q3 Sep 2025 | $4.1B | $331M | $1.93 |
| Q2 Jun 2025 | $4.02B | $266M | $1.54 |
| Q1 Mar 2025 | $3.83B | $249M | $1.40 |
| Q4 Dec 2024 | $3.96B | $437M | $2.42 |
| Q3 Sep 2024 | $3.9B | $285M | $1.55 |
Sector & industry today
LiveSectors
- Real Estate+1.01%
- Consumer Cyclical+0.94%
- Energy+0.84%
- Consumer Defensive+0.82%
- Financial Services+0.23%
- Basic Materials-0.11%
- Healthcare-0.18%
- Communication Services-0.18%
- Industrials-0.47%
- Technology-0.85%
- Utilities-1.03%
Top industries (issuer's industry highlighted)
- Medical - Diagnostics & Research+0.04%
- Software - Services+9.60%
- Broadcasting+8.34%
- Travel Services+7.87%
- Computer Hardware+4.56%
- Oil & Gas Energy-3.54%
- Biotechnology+3.28%
- Electrical Equipment & Parts-3.26%
- Semiconductors-2.12%
- Communication Equipment+2.06%
- REIT - Healthcare Facilities+2.01%
- Drug Manufacturers - Specialty & Generic+1.99%
Analyst view
DB · price_targets + analyst_gradesConsensus target
$225.63
+31.73% upside
Low
$185.00
Median
$230.00
High
$250.00
Recent actions
0 ↑0 ↓8 hold
- Apr 01, 2026
- Mar 01, 2026
- Feb 01, 2026
- Jan 01, 2026
- Dec 01, 2025
News
DB · news_items- StackAdapt Teams Up with IQVIA Digital's MediaOS to Power Healthcare Advertisingbusinesswire.com·Jun 18, 2026
- StackAdapt Teams Up with IQVIA Digital's MediaOS to Power Healthcare Advertisingbusinesswire.com·Jun 18, 2026
- Why IQVIA Holdings (IQV) is a Top Value Stock for the Long-Termzacks.com·Jun 17, 2026
- Here's Why IQVIA Holdings (IQV) is a Strong Momentum Stockzacks.com·Jun 15, 2026
- Wiley and IQVIA Release Cross-Sector Report on AI's Promise and Pressure Points Across Healthcare Value Chainbusinesswire.com·Jun 15, 2026
- Wiley and IQVIA Release Cross-Sector Report on AI's Promise and Pressure Points Across Healthcare Value Chainbusinesswire.com·Jun 15, 2026
- IQVIA (IQV) Up 3.2% Since Last Earnings Report: Can It Continue?zacks.com·Jun 04, 2026
- IQVIA Holdings Inc. (IQV) Presents at Jefferies Global Healthcare Conference 2026 Transcriptseekingalpha.com·Jun 03, 2026
Recent analyst activity
DB- Jun 17, 2026PT$200.00Iqvia downgraded to Equal Weight from Overweight at Morgan StanleyMorgan Stanley
- Jun 17, 2026GradeOverweight → Equal-WeightMorgan Stanley Downgrades IQVIA Holdings (IQV) to EqualweightMorgan Stanley
- Jun 05, 2026GradeOutperform → OutperformRBC Capital: 'Miebo remains the second-largest Rx DED drug in the US with 22.8% market share'RBC Capital
- Jun 03, 2026PT$210.00Iqvia price target lowered to $210 from $240 at HSBCHSBC
Financial scores
DBJun 23, 2026Altman Z
1.82
Grey
≥ 3.0 safe · 1.81–3.0 grey · < 1.81 distress
Piotroski F
5/9
Average
≥ 7 strong · 4–6 average · < 4 weak
Peers
Total assets
$29.94B
Total debt
$16.17B
Cash & equiv
$1.98B
Operating CF
$2.65B
Free cash flow
$2.05B
Buybacks
-$1.24B
Recent insiders
All →| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
BOUSBIB ARI director, officer: See Remarks | Sell | 36,564 | $8.13M | Dec 18, 2025 |
BOUSBIB ARI director, officer: See Remarks | Sell | 7,315 | $1.6M | Oct 29, 2025 |
BOUSBIB ARI director, officer: See Remarks | Sell | 3,973 | $881.89K | Oct 29, 2025 |
BOUSBIB ARI director, officer: See Remarks | Sell | 13,741 | $3.01M | Oct 29, 2025 |
BOUSBIB ARI director, officer: See Remarks | Sell | 26,128 | $5.78M | Oct 29, 2025 |
BOUSBIB ARI director, officer: See Remarks | Sell | 800 | $174.06K | Oct 29, 2025 |
Income statement · annual
5y| Period | Revenue | Op income | Net income | EPS | Net margin |
|---|---|---|---|---|---|
| FY 2025 | $16.31B | $2.29B | $1.36B | $7.84 | +8.34% |
| FY 2024 | $15.41B | $2.2B | $1.37B | $7.49 | +8.91% |
| FY 2023 | $14.98B | $1.98B | $1.36B | $7.29 | +9.06% |
| FY 2022 | $14.41B | $1.8B | $1.09B | $5.72 | +7.57% |
| FY 2021 | $13.87B | $1.39B | $966M | $4.95 | +6.96% |